Black Hawk Acquisition Corporation (BKHA)
BKHA trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$12.48
-4.00% on the day
Market cap
$51.8M
Micro cap
Revenue
Blank-check company: no operating revenue
Net income
Blank-check company: no operating revenue
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Market cap: Computed: 4,153,577 shares (SEC cover page, 2026-10-06) x $12.48.
Profile
| Field | Value |
|---|---|
| Ticker | BKHA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0002000775 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
Financials
Blank-check company: no operating revenue.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2026-09-22 |
| Latest annual report | 10-K/A | 2026-04-28 |
| Latest quarterly / interim | 10-Q | 2026-10-06 |
| Latest current report | 8-K | 2026-10-13 |
| Latest proxy | DEFA14A | 2025-07-08 |
Source: SEC EDGAR submissions feed, 115 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| BKHAR | Black Hawk Acquisition Corporation Rights | $1.61 |
| BKHAU | Black Hawk Acquisition Corporation Units | $12.60 |
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| INKT | MiNK Therapeutics Inc. | $10.23 | -2.85% | $52.2M |
| ELOX | Eloxx Pharmaceuticals Inc. | $12.70 | -8.57% | $51.3M |
| KLRS | Kalaris Therapeutics Inc. | $2.23 | -1.33% | $53.1M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| IMA | ImageneBio Inc. | $4.24 | -0.23% | $48.1M |
| INMB | INmune Bio Inc. | $1.68 | -5.62% | $46.6M |
| LONA | LeonaBio Inc. | $6.43 | +4.30% | $60.6M |
| EXOZ | eXoZymes Inc. | $4.59 | -9.11% | $42.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier